MedPath

Rose oil aromatherapy treatments for diysmenorrhea

Not Applicable
Recruiting
Conditions
Primary dysmenorrhea.
Primary dysmenorrhea
Registration Number
IRCT20180324039145N2
Lead Sponsor
Department of Obstetrics and Gynecology, Faculty of Medicine, Ahi Evran University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
86
Inclusion Criteria

The patients diagnosed the primary dysmenorrhea
have a painful menstrual period complaint
in the ASA (American Society of Anesthesiologists) I risk group
in the age range of 18-24 years old

Exclusion Criteria

The patients who are constantly using analgesics for other reasons
The patients who are treated for any upper respiratory tract disease that may cause edema in the nasal mucosa and may prevent smelling
The patients who have anosmia diagnosed by otorhinolaryngologists
The patients who have abnormal menstrual bleeding
The patients who have allergies to rose oil and analgesic drugs, the asthma-like respiratory disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Visuel analog scale (VAS) pain scores. Timepoint: Before and after administration in the menstrual period for each patient. Method of measurement: Visuel analog scale (VAS) (between 1-10 score).
Secondary Outcome Measures
NameTimeMethod
Analgesic consumption of the patients for twenty-four hours. Timepoint: First twenty-four hours. Method of measurement: Asking from patients.
© Copyright 2025. All Rights Reserved by MedPath